Update on Antibiotic Therapy for Dental Implants and Beyond - On Demand Access
-
You must log in to register
- Member - $50
- Resident Member - Free!
- Allied Staff Member - $50
- Professional Staff Nonmember - $100
- Other Nonmember - $100
Several new evidence-based studies have led to a renewed scrutiny regarding the role antibiotics play in the success of dental implant therapy. This 60-minute webinar will provide a thorough literature review on this topic. Penicillin-allergic patients may have a higher risk of implant failure due to factors still poorly understood, and the widespread use of alternative antibiotics in such patients can create detrimental healthcare issues that extend beyond the dental implant. Therefore, clinicians should consider having a discussion with penicillin-allergic patients about the possibility of delabeling the penicillin allergy. Good antibiotic stewardship may play an important role not only in dental implant success, but in all aspects of oral and maxillofacial surgery.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Identify if antibiotics have an impact on success rates of dental implants.
- Explain why clindamycin may be detrimental to the overall healthcare management of the dental implant patient.
- Create an antibiotic protocol for patients in all scenarios, which represents good antibiotic stewardship.
An Internet-based CDE/CME Activity
Original Release Date: March 28, 2024
Expiration Date: March 28, 2027
Estimated time to complete this educational activity: 1.0 hour
Method of participation: Self-Study
Naushad R. Edibam, DMD
Dr. Naushad Edibam obtained his DMD degree from Boston University’s Goldman School of Dental Medicine and then completed a one-year internship and four-year residency program in oral and maxillofacial surgery at Loyola University Medical Center. Dr. Edibam is a nominated member of Omicron Kappa Upsilon, a Diplomate of ABOMS and the National Dental Board of Anesthesiology, and a fellow of the American Dental Society of Anesthesiology. He also is a clinical instructor at Yale New Haven Hospital’s oral and maxillofacial surgery residency program and was a 2022 recipient of the Bernard Levine Teacher of the Year Award in Oral and Maxillofacial Surgery, awarded by the graduating OMS residents. Additionally, he maintains a private practice in oral and maxillofacial surgery in Stamford, Conn.
Disclosures: No relevant financial relationships were disclosed.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.